Elevated levels of IP-10 and monocyte chemoattractant protein-1 (MCP-1) in the serum of patients with severe COVID-19 have been noted, suggesting that these are biomarkers associated with the disease severity (22). This evidence concerns the gene CCL2 and COVID-19.